Myelodysplastic syndromes: clinical practice guidelines in oncology.
Publication
, Journal Article
Greenberg, PL; Attar, E; Bennett, JM; Bloomfield, CD; Borate, U; De Castro, CM; Deeg, HJ; Frankfurt, O; Gaensler, K; Garcia-Manero, G; Gore, SD ...
Published in: J Natl Compr Canc Netw
July 2013
The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid lineages, and the potential for development of acute myeloid leukemia. These disorders primarily affect older adults. The NCCN Clinical Practice Guidelines in Oncology for MDS provide recommendations on the diagnostic evaluation and classification of MDS, risk evaluation according to established prognostic assessment tools (including the new revised International Prognostic Scoring System), treatment options according to risk categories, and management of related anemia.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
July 2013
Volume
11
Issue
7
Start / End Page
838 / 874
Location
United States
Related Subject Headings
- Transplantation, Homologous
- Prognosis
- Oncology & Carcinogenesis
- Myelodysplastic Syndromes
- Immunologic Factors
- Humans
- Hematopoietic Stem Cell Transplantation
- Hematinics
- Antineoplastic Agents
- Anemia
Citation
APA
Chicago
ICMJE
MLA
NLM
Greenberg, P. L., Attar, E., Bennett, J. M., Bloomfield, C. D., Borate, U., De Castro, C. M., … Naganuma, M. (2013). Myelodysplastic syndromes: clinical practice guidelines in oncology. J Natl Compr Canc Netw, 11(7), 838–874. https://doi.org/10.6004/jnccn.2013.0104
Greenberg, Peter L., Eyal Attar, John M. Bennett, Clara D. Bloomfield, Uma Borate, Carlos M. De Castro, H Joachim Deeg, et al. “Myelodysplastic syndromes: clinical practice guidelines in oncology.” J Natl Compr Canc Netw 11, no. 7 (July 2013): 838–74. https://doi.org/10.6004/jnccn.2013.0104.
Greenberg PL, Attar E, Bennett JM, Bloomfield CD, Borate U, De Castro CM, et al. Myelodysplastic syndromes: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2013 Jul;11(7):838–74.
Greenberg, Peter L., et al. “Myelodysplastic syndromes: clinical practice guidelines in oncology.” J Natl Compr Canc Netw, vol. 11, no. 7, July 2013, pp. 838–74. Pubmed, doi:10.6004/jnccn.2013.0104.
Greenberg PL, Attar E, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, Frankfurt O, Gaensler K, Garcia-Manero G, Gore SD, Head D, Komrokji R, Maness LJ, Millenson M, O’Donnell MR, Shami PJ, Stein BL, Stone RM, Thompson JE, Westervelt P, Wheeler B, Shead DA, Naganuma M. Myelodysplastic syndromes: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2013 Jul;11(7):838–874.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
July 2013
Volume
11
Issue
7
Start / End Page
838 / 874
Location
United States
Related Subject Headings
- Transplantation, Homologous
- Prognosis
- Oncology & Carcinogenesis
- Myelodysplastic Syndromes
- Immunologic Factors
- Humans
- Hematopoietic Stem Cell Transplantation
- Hematinics
- Antineoplastic Agents
- Anemia